These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 28498846)
1. MeCP2 recognizes cytosine methylated tri-nucleotide and di-nucleotide sequences to tune transcription in the mammalian brain. Lagger S; Connelly JC; Schweikert G; Webb S; Selfridge J; Ramsahoye BH; Yu M; He C; Sanguinetti G; Sowers LC; Walkinshaw MD; Bird A PLoS Genet; 2017 May; 13(5):e1006793. PubMed ID: 28498846 [TBL] [Abstract][Full Text] [Related]
2. Neuronal non-CG methylation is an essential target for MeCP2 function. Tillotson R; Cholewa-Waclaw J; Chhatbar K; Connelly JC; Kirschner SA; Webb S; Koerner MV; Selfridge J; Kelly DA; De Sousa D; Brown K; Lyst MJ; Kriaucionis S; Bird A Mol Cell; 2021 Mar; 81(6):1260-1275.e12. PubMed ID: 33561390 [TBL] [Abstract][Full Text] [Related]
3. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome. Chen L; Chen K; Lavery LA; Baker SA; Shaw CA; Li W; Zoghbi HY Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5509-14. PubMed ID: 25870282 [TBL] [Abstract][Full Text] [Related]
4. DNA methylation in the gene body influences MeCP2-mediated gene repression. Kinde B; Wu DY; Greenberg ME; Gabel HW Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15114-15119. PubMed ID: 27965390 [TBL] [Abstract][Full Text] [Related]
5. Plasticity at the DNA recognition site of the MeCP2 mCG-binding domain. Lei M; Tempel W; Chen S; Liu K; Min J Biochim Biophys Acta Gene Regul Mech; 2019 Sep; 1862(9):194409. PubMed ID: 31356990 [TBL] [Abstract][Full Text] [Related]
6. MeCP2 is a microsatellite binding protein that protects CA repeats from nucleosome invasion. Ibrahim A; Papin C; Mohideen-Abdul K; Le Gras S; Stoll I; Bronner C; Dimitrov S; Klaholz BP; Hamiche A Science; 2021 Jun; 372(6549):. PubMed ID: 34324427 [TBL] [Abstract][Full Text] [Related]
7. Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes. Yasui DH; Peddada S; Bieda MC; Vallero RO; Hogart A; Nagarajan RP; Thatcher KN; Farnham PJ; Lasalle JM Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19416-21. PubMed ID: 18042715 [TBL] [Abstract][Full Text] [Related]
8. Disruption of DNA-methylation-dependent long gene repression in Rett syndrome. Gabel HW; Kinde B; Stroud H; Gilbert CS; Harmin DA; Kastan NR; Hemberg M; Ebert DH; Greenberg ME Nature; 2015 Jun; 522(7554):89-93. PubMed ID: 25762136 [TBL] [Abstract][Full Text] [Related]
9. Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA. Liu K; Xu C; Lei M; Yang A; Loppnau P; Hughes TR; Min J J Biol Chem; 2018 May; 293(19):7344-7354. PubMed ID: 29567833 [TBL] [Abstract][Full Text] [Related]
10. Structural Basis of MeCP2 Distribution on Non-CpG Methylated and Hydroxymethylated DNA. Sperlazza MJ; Bilinovich SM; Sinanan LM; Javier FR; Williams DC J Mol Biol; 2017 May; 429(10):1581-1594. PubMed ID: 28450074 [TBL] [Abstract][Full Text] [Related]
11. MeCP2 binding to DNA depends upon hydration at methyl-CpG. Ho KL; McNae IW; Schmiedeberg L; Klose RJ; Bird AP; Walkinshaw MD Mol Cell; 2008 Feb; 29(4):525-31. PubMed ID: 18313390 [TBL] [Abstract][Full Text] [Related]
12. Absence of MeCP2 binding to non-methylated GT-rich sequences in vivo. Connelly JC; Cholewa-Waclaw J; Webb S; Steccanella V; Waclaw B; Bird A Nucleic Acids Res; 2020 Apr; 48(7):3542-3552. PubMed ID: 32064528 [TBL] [Abstract][Full Text] [Related]
13. FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice. Deng V; Matagne V; Banine F; Frerking M; Ohliger P; Budden S; Pevsner J; Dissen GA; Sherman LS; Ojeda SR Hum Mol Genet; 2007 Mar; 16(6):640-50. PubMed ID: 17309881 [TBL] [Abstract][Full Text] [Related]
14. Radically truncated MeCP2 rescues Rett syndrome-like neurological defects. Tillotson R; Selfridge J; Koerner MV; Gadalla KKE; Guy J; De Sousa D; Hector RD; Cobb SR; Bird A Nature; 2017 Oct; 550(7676):398-401. PubMed ID: 29019980 [TBL] [Abstract][Full Text] [Related]
15. Sequence-specific DNA binding by AT-hook motifs in MeCP2. Lyst MJ; Connelly J; Merusi C; Bird A FEBS Lett; 2016 Sep; 590(17):2927-33. PubMed ID: 27461740 [TBL] [Abstract][Full Text] [Related]
16. MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome. MartÃnez de Paz A; Ausió J Adv Exp Med Biol; 2017; 978():3-21. PubMed ID: 28523538 [TBL] [Abstract][Full Text] [Related]
17. Mecp2-null mice provide new neuronal targets for Rett syndrome. Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361 [TBL] [Abstract][Full Text] [Related]
18. Regulation mechanism and research progress of MeCP2 in Rett syndrome. Yang W; Pan H Yi Chuan; 2014 Jul; 36(7):625-30. PubMed ID: 25076025 [TBL] [Abstract][Full Text] [Related]
20. Complete Profiling of Methyl-CpG-Binding Domains for Combinations of Cytosine Modifications at CpG Dinucleotides Reveals Differential Read-out in Normal and Rett-Associated States. Buchmuller BC; Kosel B; Summerer D Sci Rep; 2020 Mar; 10(1):4053. PubMed ID: 32132616 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]